Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 731

Showing 1-25 of 731 citing articles:

Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Marie‐Ève Piché, André Tchernof, Jean–Pierre Després
Circulation Research (2020) Vol. 126, Iss. 11, pp. 1477-1500
Open Access | Times Cited: 1269
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
Kenneth Cusi, Scott Isaacs, Diana Barb, et al.
Endocrine Practice (2022) Vol. 28, Iss. 5, pp. 528-562
Open Access | Times Cited: 631
The burden and risks of emerging complications of diabetes mellitus
Dunya Tomic, Jonathan E. Shaw, Dianna J. Magliano
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 9, pp. 525-539
Open Access | Times Cited: 597
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Matthew J. Watt, Paula M. Miotto, William De Nardo, et al.
Endocrine Reviews (2019) Vol. 40, Iss. 5, pp. 1367-1393
Open Access | Times Cited: 473
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper, Anna Martin, Sonja Lang, et al.
Clinical Research in Cardiology (2020) Vol. 110, Iss. 7, pp. 921-937
Open Access | Times Cited: 457
PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Sergio Rius‐Pérez, Isabel Torres-Cuevas, Iván Millán, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-20
Open Access | Times Cited: 452
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 437
Causes, consequences, and treatment of metabolically unhealthy fat distribution
Norbert Stefan
The Lancet Diabetes & Endocrinology (2020) Vol. 8, Iss. 7, pp. 616-627
Closed Access | Times Cited: 426
Global pandemics interconnected — obesity, impaired metabolic health and COVID-19
Norbert Stefan, Andreas L. Birkenfeld, Matthias B. Schulze
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 3, pp. 135-149
Open Access | Times Cited: 414
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 4, pp. 284-296
Closed Access | Times Cited: 390
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
P. Barton Duell, Francine K. Welty, Michael Miller, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 6
Open Access | Times Cited: 371
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Fasiha Kanwal, Jay H. Shubrook, Leon A. Adams, et al.
Gastroenterology (2021) Vol. 161, Iss. 5, pp. 1657-1669
Open Access | Times Cited: 366
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review
Rohit Loomba, Joseph K. Lim, Heather Patton, et al.
Gastroenterology (2020) Vol. 158, Iss. 6, pp. 1822-1830
Open Access | Times Cited: 293
Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
Manuel F. Landecho, Carlota Tuero, Víctor Valentí, et al.
Nutrients (2019) Vol. 11, Iss. 11, pp. 2664-2664
Open Access | Times Cited: 257
Epidemiology and risk-stratification of NAFLD-associated HCC
George N. Ioannou
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1476-1484
Open Access | Times Cited: 253
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
Romina Lomonaco, Eddison Godinez Leiva, Fernando Bril, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 399-406
Open Access | Times Cited: 246
Dietary Fructose and the Metabolic Syndrome
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 237
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Seong Hee Kang, Hye Won Lee, Jeong‐Ju Yoo, et al.
Clinical and Molecular Hepatology (2021) Vol. 27, Iss. 3, pp. 363-401
Open Access | Times Cited: 222
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
Emir Muzurović, Dimitri P. Mikhailidis, Christos S. Mantzoros
Metabolism (2021) Vol. 119, pp. 154770-154770
Closed Access | Times Cited: 191
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada
Nutrients (2019) Vol. 11, Iss. 3, pp. 677-677
Open Access | Times Cited: 187
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard, Jan Borén, Marja‐Riitta Taskinen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 183
Implications of altered NAD metabolism in metabolic disorders
Keisuke Okabe, Keisuke Yaku, Kazuyuki Tobe, et al.
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 173
Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study
Xiao-Jun Ge, Limei Zheng, Mei Wang, et al.
BMJ Open (2020) Vol. 10, Iss. 8, pp. e036663-e036663
Open Access | Times Cited: 164
The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study
Jiarong Xie, Hangkai Huang, Zhening Liu, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 949-964
Open Access | Times Cited: 154
Imaging biomarkers of NAFLD, NASH, and fibrosis
Veeral Ajmera, Rohit Loomba
Molecular Metabolism (2021) Vol. 50, pp. 101167-101167
Open Access | Times Cited: 150
Page 1 - Next Page

Scroll to top